Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study
OPEN BMJ (Clinical research ed.) | 12 May 2016
A Weill, M Dalichampt, F Raguideau, P Ricordeau, PO Blotière, J Rudant, F Alla and M Zureik
To assess the risk of pulmonary embolism, ischaemic stroke, and myocardial infarction associated with combined oral contraceptives according to dose of oestrogen (ethinylestradiol) and progestogen.
* Data courtesy of Altmetric.com